Treating rare blood cancers
Patients with a group of cancers known as advanced systemic mastocytosis have few treatment options. A drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Leonard appointed chair of pediatrics
The clinical research expert will lead the Department of Pediatrics and serve as physician-in-chief of Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health.
Medicine X Week is Sept. 12-18
This year’s conference will offer opportunities for participants to hone the skills needed to implement new ideas for health-care change in their communities.
Breakthrough in understanding psoriasis
Researchers have discovered a protein involved in psoriasis, a highly common skin disease, opening up new potentials for therapy.
Assisted suicide supported across ethnicities
A survey regarding attitudes toward physician-assisted death was published June 9 — the day that the practice took effect in California.
Brain activity during cooperation differs by sex
When the researchers asked people to cooperate with a partner, then tracked the brain activity of both participants, they found that males and females had different patterns of shared brain activity.
Proposal to expand treatment of worm infections
A study supports a greatly expanded treatment program for parasitic worm diseases that could save millions from disability and possible death in sub-Saharan Africa.
Stem-cell therapy for stroke trial successful
People disabled by a stroke demonstrated substantial recovery long after the event when modified adult stem cells were injected into their brains.
Keeping muscle stem cells happy in the lab
Artificial collagen-based muscle fibers and a specialized broth developed by Stanford researchers help muscle stem cells stay primed and ready for transplant.
Supportive care lacking among dying cancer patients
All patients with advanced cancer should receive both palliative and hospice care before death, yet a study shows only half of veterans receive palliative care, and the use of hospice depends on the care environment.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.